FierceBiotech Radio on GlaxoSmithKline rumors, Allergan's new identity and Axovant's IPO

FiercePharma's Carly Helfand and FierceBiotech's Damian Garde discuss the week's biggest news in biopharma, including buyout rumors surrounding GlaxoSmithKline, the new face of Allergan and a biotech IPO that's turning heads around the industry.

Download the episode on iTunes or Stitcher, or listen below--and be sure to subscribe. Let us know what you think by dropping a line to radio@fiercebiotech.com. If you missed last week's double episode from the BIO conference, find it here.

Read more on